Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ETV6 encodes an ETS family transcription factor. Additionally we are shipping ETV6 Proteins (4) and ETV6 Kits (2) and many more products for this protein.
Showing 10 out of 99 products:
Human Monoclonal ETV6 Primary Antibody for IHC (p), ELISA - ABIN560810
Meester-Smoor, Janssen, ter Haar, van Wely, Aarnoudse, van Oord, van Tilburg, Zwarthoff: The ETS family member TEL binds to nuclear receptors RAR and RXR and represses gene activation. in PLoS ONE 2011
Show all 2 references for ABIN560810
Human Polyclonal ETV6 Primary Antibody for IF, ELISA - ABIN1533723
Golub, Barker, Lovett, Gilliland: Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. in Cell 1994
Show all 2 references for ABIN1533723
Chicken Polyclonal ETV6 Primary Antibody for WB - ABIN2792591
Rubnitz, Wichlan, Devidas, Shuster, Linda, Kurtzberg, Bell, Hunger, Chauvenet, Pui, Camitta, Pullen: Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008
Chicken Polyclonal ETV6 Primary Antibody for IHC, WB - ABIN2792592
Schick, Oakeley, Hynes, Badache: TEL/ETV6 is a signal transducer and activator of transcription 3 (Stat3)-induced repressor of Stat3 activity. in The Journal of biological chemistry 2004
Dominant-negative truncated ETV6 with deletions of the ETS (show ETS1 Antibodies) domain or the PNT (show ETS2 Antibodies) domain interfered with repression by full-length ETV6 and affected expression of early hematopoietic and erythroid markers in embryos.
the transcriptional repressor Tel plays an evolutionarily conserved role in angiogenesis: it is indispensable for the sprouting of human endothelial cells and for normal development of the Danio rerio blood circulatory system
the ETV6-NTRK3 fusion (show NTRK3 Antibodies) might identify a subset of gastrointestinal stromal tumours with peculiar clinicopathological characteristics
our results demonstrate that MIR181A1 and ETV6/RUNX1 (show RUNX1 Antibodies) regulate each other, and we propose that a double negative loop involving MIR181A1 and ETV6/RUNX1 (show RUNX1 Antibodies) may contribute to ETV6/RUNX1 (show RUNX1 Antibodies)-driven arrest of differentiation in pre-B ALL.
germline ETV6 mutations associated with leukemia and thrombocytopenia were identifies in multiple individuals. Mutant ETV6 showed decreased ability to regulate expression of other genes.
We observed significant enrichment of the neuroactive ligand-receptor interaction pathway in TCF3 (show TCF3 Antibodies)-PBX1 (show PBX1 Antibodies) as well as an enrichment of genes involved in immunity and infection pathways in ETV6-RUNX1 (show RUNX1 Antibodies) subtype
Our study demonstrated that ETV6 was markedly involved in the development of non-small cell lung cancer and could serve as a potential prognostic marker for this deadly disease
Suggest germline ETV6 variations as the basis of a novel genetic syndrome associated with predisposition to childhood acute lymphoblastic leukemia.
Molecular analysis of ETV6 gene rearranged mammary analogue secretory carcinoma of salivary glands tumors with lack of classical ETV6-NTRK3 fusion (show NTRK3 Antibodies).
the ETV6/ARG oncoprotein contributes to autonomous cell growth by compensating for the requirement of growth factor through activating STAT5 (show STAT5A Antibodies) signaling, which leads to the up-regulation of c-Myc (show MYC Antibodies).
TEL-AML1 (show RUNX1 Antibodies) fusion protein blocks B-cell differentiation and downregulates the IRF3 (show IRF3 Antibodies)-IFNalpha/beta pathway by modulating expression and phosphorylation of IRF3 (show IRF3 Antibodies) in human primary hematopoietic precursor cells.
Spectrum of secretory breast carcinoma with ETV6-NTRK3 (show NTRK3 Antibodies) gene fusion ranging from low-grade to high-grade histology, with occasional low hormonal receptor expression, simplex genomic profiles, and possible unfavorable course.
ETV6 DNA binding inhibition is established by the stability of its inhibitory helix
Studied the combination of Etv6-RUNX1 (show RUNX1 Antibodies) and Pax5 (show PAX5 Antibodies)(+/-) alleles, they generated a transplantable B220 (show PTPRC Antibodies) + CD19 (show CD19 Antibodies)+ B-ALL with a significant disease incidence; RNA-seq analysis showed a gene expression pattern consistent with arrest at the pre-B stage.
In murine models of B-cell progenitors, evidence found that ETV6- RUNX1 (show RUNX1 Antibodies) alters the expression of cytoskeletal regulatory genes, resulting in a block of the CDC42 (show CDC42 Antibodies) signaling pathway, and compromises the chemotactic response to CXCL12 (show CXCL12 Antibodies).
ETV6-SAM (show TTN Antibodies) domain interface mutations block ETV6-NTRK3 (show NTRK3 Antibodies)-induced cellular transformation
the autoinhibition of ETV6 DNA binding by sequences C-terminal to its ETS (show ETS1 Antibodies) domain
find that both IRS1 (show IRS1 Antibodies) and kinase active IGF1R (show IGF1R Antibodies) are required for ETV6-NTRK3 (show NTRK3 Antibodies) transformation, that tyrosine phosphorylated IRS1 (show IRS1 Antibodies) is present in high molecular weight complexes with EN and IGF1R (show IGF1R Antibodies), and that EN colocalizes with IGF1R (show IGF1R Antibodies) at the plasma membrane
Cytogenetic study of 33 children with ETV6-RUNX1 (show RUNX1 Antibodies) positive acute lymphoblastic leukemia predict long term survival.
TEL binding to IRF-8 (show IRF8 Antibodies) for recruitment of HDAC3 (show HDAC3 Antibodies) is regulated by gamma-interferon (show IFNG Antibodies)
the ability of TEL to repress transcription and suppress growth is regulated by sumoylation and nuclear export
nucleo-cytoplasmic delocalization of the major isoform of TEL-ETV6 is regulated by V-src (show SRC Antibodies)
This gene encodes an ETS family transcription factor. The product of this gene contains two functional domains: a N-terminal pointed (PNT) domain that is involved in protein-protein interactions with itself and other proteins, and a C-terminal DNA-binding domain. Gene knockout studies in mice suggest that it is required for hematopoiesis and maintenance of the developing vascular network. This gene is known to be involved in a large number of chromosomal rearrangements associated with leukemia and congenital fibrosarcoma.
transcription factor ETV6
, ets variant gene 6 (TEL oncogene)
, TEL oncogene
, ets variant 6
, ETS translocation variant 6
, ETS-related protein Tel1
, TEL1 oncogene
, ets domain protein